Comparative Analysis of Clinical and Medication Information between Chronic Hepatitis B Patients with Damp Heat Syndrome and Spleen Deficiency Syndrome
Table 3
Analysis of factors related to the decrease of ALT.
ALT decreased by more than 30%
Crude OR [95% CI]
Adjusted OR† [95% CI]
DH syndrome
4.854 (1.149, 20.501)
0.032
4.936(1.144, 21.307)
0.032
Medication
Antiviral therapy
1.638 (0.329, 8.143)
0.547
1.638 (0.329, 8.143)
0.547
Hepatoprotective drugs
0.561 (0.136, 2.313)
0.424
0.542 (0.123, 2.382)
0.418
Drugs that promote bile excretion
1.371 (0.303, 6.206)
0.682
1.517 (0.235, 9.777)
0.661
Chinese herbal medicine
0.292 (0.05, 1.728)
0.175
0.26 (0.04, 1.684)
0.158
Untreated
0.883 (0.118, 6.604)
0.904
1.025 (0.124, 8.453)
0.982
Analysis of factors related to the decrease of ALT in patients with ALT >50 U/L at baseline of group A&D. Crude OR estimated by the simple logistic regression model. †Adjusted OR estimated by multiple logistic regression models including age, gender, and HBV-DNA value as covariates.
